| Investment Insights |
| Our regular features on investments and equity picks for our investors. |
| FROM SHAREKHAN'S DESK Volatility gets an extension It has been a sombre beginning for this equity market this year. The benchmark index registered a double-digit decline over the past one month even as the equities markets rallied globally. In the year to date India is the second worst performing market globally with Egypt being the worst. Our market dropped on macro-economic concerns of persistently high inflation, hardening of interest rates and an unexpected sharp slowdown in the industrial production. Even though corporate earnings for Q3FY2011 were largely in line with expectations, the market witnessed earnings downgrades in several companies across sectors on account of concerns related to margin pressure from the rising raw material cost and spiraling energy prices. The eruption of social unrest in Egypt and some other countries in the neighbouring region towards the end of the month added to the market?s woes. Given the global concerns and certain India-specific issues, the foreign institutional investor (FII) flows reversed with the foreign investors withdrawing close to one billion dollars in January 2011 alone. SHAREKHAN TOP PICKS
STOCK IDEA
STOCK UPDATE
THE STOCK IDEAS REPORT CARD SHAREKHAN SPECIAL
MUTUAL GAINS
SECTOR UPDATE
VIEWPOINT
Earnings Guide
|
| Trader's Techniques |
| Get in-depth technical research and hot opportunities in the equities, derivatives and commodities markets. |
|
| Commodities Corner |
| Get view on the buzzing commodities from our fundamental research team. |
|
| PMS Products |
| Get view on the PMS products and their performance from our fundamental managers. |
|
| Premier Ideas |
| Sift through the collection of model portfolios to evaluate your investment and trading strategies. |
|
Sensex
|
Monday, February 07, 2011
sharekhan ValueGuide: Volatility gets an extension
Sunday, February 06, 2011
Sarthak Industries Ltd: Financial Results for Dec 31, 2010
Sarthak Industries Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Goenka Diamond & Jewels Ltd: Financial Results for Dec 31, 2010
Goenka Diamond & Jewels Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Arihants Securities Ltd: Financial Results for Dec 31, 2010
Arihants Securities Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Kemrock Industries and Exports Ltd: Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Kemrock Industries and Exports Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSERead More
Pankaj Polymers Ltd: Board Meeting on Feb 14, 2011
Pankaj Polymers Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2011, inter alia, to consider the following:
1. Un-audited Financial Results and the Segment Report of the Company for the Third Quarter ended December 31, 2010.
2. To evaluate restructuring options including de-merger of the PP Disposable Segment business of the Company into a separate Company.
1. Un-audited Financial Results and the Segment Report of the Company for the Third Quarter ended December 31, 2010.
2. To evaluate restructuring options including de-merger of the PP Disposable Segment business of the Company into a separate Company.
Mahindra Lifespace Developers Ltd: Financial Results for Dec 31, 2010
Mahindra Lifespace Developers Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Sakthi Finance Ltd: Financial Results for Dec 31, 2010
Sakthi Finance Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Natraj Proteins Ltd: Financial Results for Dec 31, 2010
Natraj Proteins Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Read More
Aurobindo Pharma Ltd: Announces Q3 results
Aurobindo Pharma Ltd has announced the following Unaudited results for the quarter ended December 31, 2010:
The Company has posted a net profit of Rs 1838.50 million for the quarter ended December 31, 2010 as compared to Rs 1482.60 million for the quarter ended December 31, 2009. Total Income has increased from Rs 8131.50 million for the quarter ended December 31, 2009 to Rs 11576.60 million for the quarter ended December 31, 2010.
The Consolidated Results are as follows
The Unaudited results for the quarter ended December 31, 2010:
The Group has posted a net profit of Rs 1886.30 million for the quarter ended December 31, 2010 as compared to Rs 1717.70 million for the quarter ended December 31, 2009. Total Income has increased from Rs 9252.50 million for the quarter ended December 31, 2009 to Rs 11980.80 million for the quarter ended December 31, 2010.Read More
The Company has posted a net profit of Rs 1838.50 million for the quarter ended December 31, 2010 as compared to Rs 1482.60 million for the quarter ended December 31, 2009. Total Income has increased from Rs 8131.50 million for the quarter ended December 31, 2009 to Rs 11576.60 million for the quarter ended December 31, 2010.
The Consolidated Results are as follows
The Unaudited results for the quarter ended December 31, 2010:
The Group has posted a net profit of Rs 1886.30 million for the quarter ended December 31, 2010 as compared to Rs 1717.70 million for the quarter ended December 31, 2009. Total Income has increased from Rs 9252.50 million for the quarter ended December 31, 2009 to Rs 11980.80 million for the quarter ended December 31, 2010.Read More
Subscribe to:
Posts (Atom)